Business Standard

A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

Torrent Pharma buys two gynaecology products from Swiss firm Novartis AG

Acquisition of Regestrone & Pregachieve brands to further fortify Torrent Pharma's hormone segment

BS B2B Bureau  |  Mumbai 

Torrent Pharma buys two gynaecology products from Swiss firm Novartis AG

Ahmedabad based has acquired two products from Switzerland-based AG for an undisclosed amount. “The company has completed the acquisition of and brands for India from global pharma player AG,” said yesterday in a press statement. These brands are widely prescribed by gynaecologists for the management of abnormal uterine bleeding, peri & post- menopausal symptoms and infertility. 

Women healthcare is an important therapy area for Torrent Pharma, which it intends to focus in the future. With acquisition of key brands of Elder like Shelcal and Deviry, impetus on this therapy area has also increased. and will further fortify the hormone segment. 

“The use of hormones among the gynaecologists is on an increase because of lifestyle changes. This acquisition would reaffirm Torrent’s commitment towards the key important therapy of women healthcare,” added the release.

RECOMMENDED FOR YOU

Torrent Pharma buys two gynaecology products from Swiss firm Novartis AG

Acquisition of Regestrone & Pregachieve brands to further fortify Torrent Pharma's hormone segment

Acquisition of Regestrone & Pregachieve brands to further fortify Torrent Pharma's hormone segment
Ahmedabad based has acquired two products from Switzerland-based AG for an undisclosed amount. “The company has completed the acquisition of and brands for India from global pharma player AG,” said yesterday in a press statement. These brands are widely prescribed by gynaecologists for the management of abnormal uterine bleeding, peri & post- menopausal symptoms and infertility. 

Women healthcare is an important therapy area for Torrent Pharma, which it intends to focus in the future. With acquisition of key brands of Elder like Shelcal and Deviry, impetus on this therapy area has also increased. and will further fortify the hormone segment. 

“The use of hormones among the gynaecologists is on an increase because of lifestyle changes. This acquisition would reaffirm Torrent’s commitment towards the key important therapy of women healthcare,” added the release.

image
Business Standard
177 22

Torrent Pharma buys two gynaecology products from Swiss firm Novartis AG

Acquisition of Regestrone & Pregachieve brands to further fortify Torrent Pharma's hormone segment

Ahmedabad based has acquired two products from Switzerland-based AG for an undisclosed amount. “The company has completed the acquisition of and brands for India from global pharma player AG,” said yesterday in a press statement. These brands are widely prescribed by gynaecologists for the management of abnormal uterine bleeding, peri & post- menopausal symptoms and infertility. 

Women healthcare is an important therapy area for Torrent Pharma, which it intends to focus in the future. With acquisition of key brands of Elder like Shelcal and Deviry, impetus on this therapy area has also increased. and will further fortify the hormone segment. 

“The use of hormones among the gynaecologists is on an increase because of lifestyle changes. This acquisition would reaffirm Torrent’s commitment towards the key important therapy of women healthcare,” added the release.

image
Business Standard
177 22